Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% |
|
+27.78% | +53.33% |
16/07 | SciSparc Receives Nasdaq Noncompliance Notice | MT |
16/07 | SciSparc Seeks Patent for Obesity Drug Ingredient's Composition | MT |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drug Development
100.0
%
| - | - | 3 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Israel
100.0
%
| 1 | 100.0 % | 3 | 100.0 % | +113.73% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 708,438 | 708,267 ( 99.98 %) | 0 | 99.98 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
CLEARMIND MEDICINE INC. 0.24% | 7,692 | 0.24% | 12,923 $ |
Company contact information
![address Therapix Biosciences Ltd.(TRPXY)](https://cdn.zonebourse.com/static/address/114228967.png)
Sector
Sales per Business
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+25.40% | 45.35B | |
+38.38% | 24.34B | |
+26.94% | 16.51B | |
+21.19% | 14.6B | |
+71.91% | 14.27B | |
-0.05% | 6.79B | |
-11.63% | 6.57B | |
+15.08% | 5.76B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- SPRC Stock
- TRPXY Stock
- Company Therapix Biosciences Ltd.